| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | +67.4% | +147.8% |
| Cost of Revenue | $2.8M | +65.2% | +196.9% |
| Gross Profit | $95K | +171.4% | -58.0% |
| R&D Expense | $5.0M | +17.8% | +123.6% |
| SG&A Expense | $7.7M | +17.4% | +239.1% |
| Operating Income | -$14.8M | -18.4% | -181.4% |
| Interest Expense | $864K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.7M | +154.2% | -57.1% |
| Accounts Receivable | $509K | +8.8% | +187.6% |
| Inventory | $994K | -27.2% | -46.6% |
| Current Assets | $16.5M | +335.4% | +134.2% |
| Total Assets | $138.7M | +14.9% | +1629.5% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.2M | — | — |
| Capital Expenditures | $52K | — | — |
| Investing Cash Flow | -$6.6M | — | — |
| Financing Cash Flow | $28.1M | — | — |
| Free Cash Flow | -$23.3M | — | — |
| -95.0% |
| +9700.0% |
| Pre-tax Income | -$33.0M | +11.1% | -547.6% |
| Income Tax | $5K | +0.0% | — |
| Net Income | -$33.0M | +11.2% | -547.6% |
| EPS (Basic) | -$0.33 | +38.9% | +76.3% |
| EPS (Diluted) | -$0.33 | +38.9% | +76.3% |
| $24.2M |
| +197.7% |
| +673.6% |
| Total Liabilities | $39.1M | -16.0% | +951.9% |
| Stockholders' Equity | $99.5M | +34.3% | +2216.8% |